FIELD: biotechnology.
SUBSTANCE: disclosed is a method for determining activity of an immune cell, which involves the steps of bringing an immune cell into contact with an effective amount of a stimulant, for example, phytohemagglutinin (PHA) and determining the amount of cytokine produced by the immune cell. Also described are a kit for determining activity of immune cells and methods of using active immune cells as immunotherapeutic treatment.
EFFECT: invention is used to treat cancer.
14 cl, 10 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF PARTICLES BASED ON CYTOPLASMIC MEMBRANE, LIPOSOMES AND EXOSOMES FOR ANALYZING ACTIVITY OF IMMUNE CELLS | 2020 |
|
RU2829443C2 |
| METHODS FOR IMMUNOTHERAPY WITH CHIMERIC ANTIGEN RECEPTOR IN COMBINATION WITH 4-1BB AGONIST | 2019 |
|
RU2788524C2 |
| NATURAL KILLER CELLS RESISTANT TO TRANSFORMING GROWTH FACTOR BETA | 2019 |
|
RU2830178C2 |
| CHIMERIC ANTIGEN RECEPTORS WITH MUTATED CD28 COSTIMULATION DOMAINS | 2018 |
|
RU2800922C2 |
| UNIVERSAL ANTIGEN PRESENTING CELLS AND THEIR USE | 2019 |
|
RU2809113C2 |
| METHODS OF EX VIVO EXPANSION OF NATURAL KILLER CELLS AND THEIR USE | 2019 |
|
RU2814083C2 |
| METHOD FOR MALIGNANT TUMOUR DIAGNOSTICS AND DIAGNOSTIC KIT BY NK-CELLS ACTIVITY MEASUREMENT | 2012 |
|
RU2635194C2 |
| COVALENTLY CLOSED NON-CODING IMMUNOMODULATORY DNA CONSTRUCT | 2015 |
|
RU2668387C2 |
| METHOD FOR ASSESSING THE SENSITIVITY OF A TUMOR TO IMMUNO-ONCOLOGICAL DRUGS | 2021 |
|
RU2771760C1 |
| COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY | 2013 |
|
RU2832516C2 |
